Precision painkillers that are more accurate and less harmful to the liver are set to be developed by a University of Queensland spin-off company — potentially changing the lives of millions of people.
4 November 2022A potential therapy targeting difficult-to-treat immune system disorders such as rheumatoid arthritis will progress to clinical trials next year after securing $20 million in Series A funding.
1 November 2019The University of Queensland has received $24.5 million in the competitive Australian Research Council grants announced in Canberra today, securing a greater share of the pool than any other university.
6 May 2016Australian researchers aim to use a newly-funded collaboration to develop a new generation of cancer treatment, “supercharging” antibodies with a drug delivery vehicle for targeting tumours.
10 July 2011